InMode (INMD) Gross Profit Growth (3y) (2021 - 2026)
InMode (INMD) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | -11.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.17% |
| Dec 31, 2025 | -10.28% |
| Sep 30, 2025 | -10.97% |
| Jun 30, 2025 | -6.85% |
| Mar 31, 2025 | -5.05% |
| Dec 31, 2024 | -6.07% |
| Sep 30, 2024 | 9.79% |
| Jun 30, 2024 | -2.41% |
| Mar 31, 2024 | 4.86% |
| Dec 31, 2023 | 18.13% |
| Sep 30, 2023 | 26.96% |
| Jun 30, 2023 | 63.54% |
| Mar 31, 2023 | 36.86% |
| Dec 31, 2022 | 40.08% |
| Sep 30, 2022 | 43.11% |
| Jun 30, 2022 | 40.76% |
| Mar 31, 2022 | 39.37% |
| Dec 31, 2021 | 55.65% |
| Sep 30, 2021 | 54.52% |
| Jun 30, 2021 | 52.26% |